Vertex Pharmaceuticals Incorporated vs Zoom Video Communications, Inc. — how do they compare? Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B), while Zoom Video Communications, Inc. trades at $105.67 (market cap $31.10B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 4.3× Zoom Video Communications, Inc.'s market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Zoom Video Communications, Inc. nearer its low. Which is the better fit depends on your goals.
| VRTX | ZM | |
|---|---|---|
Market Cap | $134.25B | $31.10B |
Sector | Health | Technology |
52-Week High | $529.65 | $111.88 |
52-Week Low | $376.62 | $69.96 |
Enterprise Value | $128.37B | $23.44B |
Trailing returns across standard periods
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →